Related Experiment Video
Updated: Feb 28, 2026
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Polo-like kinase-1 immunoreactivity is associated with metastases in cutaneous melanoma
Maciej Kaczorowski1, Tomasz Borowiec2,3, Piotr Donizy1
1Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, Wroclaw, Poland.
Background:
Polo-like kinase-1 (PLK-1) is one of the key regulators of cell cycle progression. Increased expression of PLK-1 was observed in several tumor types.
Methods:
We immunohistochemically assessed PLK-1 expression in neoplastic and stromal compartments of 96 cutaneous melanomas, and analyzed associations between PLK-1 expression and clinicopathological characteristics.
Results:
PLK-1 expression in cancer cells was not associated with basic clinical (eg, age, gender and tumor location) or histopathological (eg, Breslow thickness, mitotic rate and ulceration) parameters. However, increased PLK-1 was more frequent in tumors with concurrent regional nodal metastases and positive sentinel lymph node biopsy status. All primary tumors associated with co-existing distant metastases exhibited high PLK-1 expression in melanoma cells. Conversely, PLK-1 expression in stromal cells was more frequent in tumors without nodal metastases. PLK-1 expression in both compartments was not associated with survival.
Conclusion:
PLK-1 expression is associated with metastatic potential in cutaneous melanoma.
